Aignostics raised €32M in a Series B round in Oct 2024. The company is based in Berlin, Germany. Investors in the round: Carma Fund, ATHOS CAPITAL, Boehringer Ingelheim Venture Fund and 4 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
